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Conclusion: Serial OCT follow-up revealed delayed tissue coverage onto both jailed
and non-jailed strut and resolution of thrombus attachment, suggesting long-term safety
of SES implantation to bifurcation lesion.
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Background: Though drug-eluting stents have dramatically improved the clinical
outcomes, percutaneous intervention for left main trunk (LMT) distal bifurcation
lesions is still challenging because of high rate of target lesion revascularization (TLR),
stent thrombosis (ST) and mortality. Recently, superiority of provisional single-stent
strategy for bifurcation lesions has been reported, however, long-term efficacy of this
approach for LMT distal bifurcation is unclear.
Methods: Eighty four consecutive patients underwent LMT distal bifurcation stenting
by scheduled provisional single-stent strategy in a single center. Sirolimus-eluting
stents were deployed in all the cases. PCI were avoided whatever possible if the lesion
had inappropriate plaque distribution for this strategy (mainly involving complex LCx
ostial disease). In all the cases, intravascular ultrasound guided procedure were
performed. Major adverse cardiac events (MACE), TLR, cardiac death, and ST were
evaluated during the follow-up period (mean 35 months).
Results: In sixty one patients (72%) final kissing balloon technique was performed,
and three (3.6%) received additional stenting (all provisional T stenting). Prevalence
of 1 year, 2 years and 3 years MACE were 6.1%, 8.9% and 13.6%, respectively. TLR
and Cardiac death occurred at 3 years were 8.0% and 1.2%, respectively. There were
no ST events during follow-up period.
Conclusion: Even though LMT distal bifurcation disease, provisional single stent
strategy for feasible lesions showed favorable long-term clinical outcomes.
TCT-304
True bifurcation: a Special Subeset?
Mario Bollati1, 4, Claudio Moretti1, Marco Di Cuia1, 4, Chiara Resmini1, 4, Fabrizio
D’Ascenzo1, 4, Giorgio Quadri1, 4, Giuseppe Biondi Zoccai3, Antonio Abbate2,
Fiorenzo Gaita1, Imad Sheiban1
1Division of Cardiology, University of Torino, Torino, Italy; 2Virginia
Commonwealth University, Richmond, VA; 3Division of Cardiology, University of
Modena e Reggio Emilia, Modena, Italy; 4MAGNIFìC Group, Torino, Italy
Background: Coronary bifurcation percutaneous treatment represents a special
coronary artery disease subset. Various techniques are been used treating these lesions,
but few data are available regarding “true” bifurcation lesions (Medina 1,1,1).
Methods: We evaluated major adverse cardiovascular events (MACE) trend in a
nation-wide retrospective registry of patients that underwent coronary bifurcation
percutaneous treatment, comparing provisional stenting technique versus both branches
PCI.
Results: We enrolled 2447 patients, with a mean follow up of 32 months (±16). 1271
were assigned to provisional group (PG, 52% of cases) and both branches PCI (BB).
Mean age was 64 years ±12 (p=0,7), LVEF 53% (p=0,4), diabetes was present in 38%
and 35% (p=0,4), chronic kidney disease in 9,7% (p=0,6). Multivessel disease
interested 39% and 36% (p=0,3) of patients. 4,6% of PCI were performed due
bifurcation restenosis in PG instead 7,6% in BB group (p=0,002). 17% of PG patients
underwent PCI due acute coronary syndrome in front of 11% of BB patients (p<0,001).
Double antiplatelet therapy duration was significantly shorter in PG (8,5 months vs
11, p<0,001) and DES usage was less represented (37% vs 43%, p<0,001). Stent
thrombosis was equally represented in the two groups (1,5% vs 2,8%, p=0,3). At
univariate analysis, PG is related to better survival free from MACE (p<0,002) and
similar overall survival (p=0,8). At Cox regression, DES usage is independently related
to greater free from mace survival (95% CI HR 0,6-0,9, p=0,04). On other hand,
restenosis as indication for PCI is a MACE predictor (95% CI HR 1,6-2,8, p<0,001).
In this setting, no differences are detected between provisional stenting and both
branches PCI.
Conclusion: Despite the complex lesion subset of true bifurcations, single stent use
(provisional approach) is related to better results in term of TLR and MACE, with
similar overall survival at middle term follow up, even after double antiplatelet per
protocol discontinuation.
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Background: Left main percutaneous coronary intervention has increased in Spain.
However, there is limited data about the outcome of these patients.
Methods: Multicentered observational, prospective registry, that included all
consecutive patients with severe left main coronary artery (LMCA) disease treated
percutaneously at 30 centers We describe patient and procedure characteristics and
follow-up at 6 and 12 months.
Results: Between 2007 and 2008, 782 patients were enrolled. 74.6% were men, mean
age was 70.8 ± 11.1 years, 41.9% were diabetic. Main indications for PCI were unstable
angina/NSTEMI in 49.8% and STEMI in 11.3%. A 7% had cardiogenic shock. 54.5%
were distal LMCA lesions, and 46.3% had both branch ostia involvement. Mean
stenosis was 74.2±15.4%, being calcified lesions 50.3%. IVUS was used in 24.8%.
86% was treated with a single stent approach, 43.4% limited to LM and 41.5%
extending to the LAD. When a 2-stent-technique was used, the crush stenting technique
was the preferred. DES was used in 79,9% . The success rate was 96.4%. In-hospital
mortality was 2.3%, excluding patients with cardiogenic shock and STEMI at
presentation. Follow-up at 6 months: 13% patients had angina or ischemia. At 12
months 15.1% patients had to be admitted to hospital, mainly due to angina or
myocardial infarction. Clinical restenosis rate was 2.5% confined to LM, 17.9% in the
ostium of the circumflex and 13.5% in the ostium of the LAD. MACE was 27.2%
(including those patients with cardiogenic shock and myocardial infarction at baseline).
Multivariate logistic regression analysis showed as independent risk factors for new
revascularization a technique with more than one stent implanted, and left circumflex
ostium involvement
Conclusion: PCI in LMCA in Spain is performed mainly in complex lesions, with a
very low mortality in patients without cardiogenic shock. A single stent approach is
the preferred technique. Among patients with distal LMCA lesions, left circumflex
ostium involvement and a technique that used more than one stent were associated
with a higher rate of repeat revascularization.
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